On-Demand Cell Line Development Webinars

31. Fast Track Your Path To Commercialization 5/21/2025

    Discover key strategies for scaling biologics from bench to pilot scale and learn how to overcome challenges in process development, including control of agitation, oxygen, CO₂, and nutrient supplementation.

32. Optimizing Biotherapeutic Protein Expression With CHO Vector Technology 5/19/2025

    Review the development of a high-strength synthetic gene promoter that enhances titers while maintaining exceptional product quality and expression stability, to support more efficient biomanufacturing.

33. From Cell Line Development To Upstream Optimization: Enhancing Biologics Quality And Productivity 4/30/2025

    Explore how advanced cell line development and upstream processing strategies optimize both productivity and therapeutic effectiveness, ensuring the development of high-quality biologics.

34. Using Data To Revolutionize Intensified Cell Line Development 4/14/2025

    Discover how N-1 perfusion and concentrated fed-batch can revolutionize biomanufacturing by exploring an advanced data analytics tool that simplifies early-stage upstream process optimization through in silico simulations.

35. Cell Line Development Tools For Rapid Prototyping 4/14/2025

    Discover rapid prototyping tools for cell line development, optimize clone selection, and learn how modern technology reduces process risks to enhance your capabilities with the latest advancements.

36. Solutions For The Clinical-Grade Manufacturing 3/31/2025

    Explore the crucial role of NK cells in the immune system and learn efficient methodologies for manufacturing gene-engineered NK cells and scaling up production.

37. New Solutions For Your Engineered Immune Cell Analytics 3/31/2025

    Discover solutions for optimizing immune cell engineering workflows, which covers target identification, product monitoring, and tools to enhance efficiency and accuracy at every stage.

38. Clinical-Grade Manufacturing Of Difficult-To-Transduce Cells 3/20/2025

    Discover how Miltenyi R&D and Bioindustry experts revolutionize cellular therapy with BaEV-env LVVs as well as gain insights into preclinical evaluations and clinical-grade product development for CAR-NK cells.

39. The Future Of Allogeneic Cell Therapy: Hypoimmunogenic Donor Cells 1/17/2025

    Explore how TARGATT™ gene editing and HLA-F technologies are revolutionizing hypoimmunogenic cell development for scalable allogeneic therapies.

40. Epitope Base Editing CD45 In Hematopoietic Cells Enables Universal Blood Cancer Immune Therapy 11/22/2024

    Researchers developed base-edited CAR T cells and CD45-edited stem cells to create universal blood cancer immunotherapy, showcasing efficacy while minimizing toxicity using MaxCyte electroporation technology.